Mandate

Vinge advises Pricer AB in connection with its issuance of senior unsecured bonds and early redemption

Vinge advises Pricer AB (publ) in connection with its issuance of floating rate senior unsecured bonds of SEK 300 million within a framework of SEK 500 million and early redemption of existing bonds.

The proceeds will be used to refinance Pricer’s existing bonds of SEK 250 million and to finance general corporate purposes, and the bonds will, in accordance with the terms and conditions, be listed on the corporate bond list of Nasdaq Stockholm. The bonds have a tenor of three years and carries an interest rate of STIBOR 3m + 400 basis points. In connection with the issuance, Pricer exercised its right to voluntary early redemption of the existing bonds.

Nordea Bank Abp has acted as sole bookrunner in the transaction.

Vinge’s team consisted of Albert Wållgren, Lionardo Ojeda, Calle Tengwall Pagels, William Carlberg Johansson, Nilufer Nouri (Banking and Finance), Dain Hård Nevonen and Benjamin Vafaeian (Capital Markets and Public M&A).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025